Tag Directory / PANCREATICCANCER     showing 1–1 of 1   RSS

for: Saturday, May 02, 2026



Vivek Subbiah: F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

oncodaily - Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn: “Wow! It’s Big news on Friday. F.D.A. Grants Early Access to Promising Drug for […]

AI Summary: The FDA has authorized early access to a promising experimental therapy for pancreatic cancer, opening an expanded‑access pathway so eligible patients can receive the drug before full approval. Regulators based the decision on encouraging early clinical signals of activity and manageable safety data, aiming to offer options for a disease with few effective treatments—because pancreatic cancer isn’t known for its patience.


Daraxonrasib expanded access: FDA opens early pathway

FDA grants expanded access to the pancreatic cancer drug daraxonrasib

2 months / medicalxpress

Maen Abdelrahim: FDA Grants Expanded Access for Daraxonrasib in Pancreatic Cancer

2 months / oncodaily

Yannick Buccella: Historic Day for the GI Oncology Community

2 months / oncodaily

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

2 months / oncodaily

Vivek Subbiah: F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

2 months / oncodaily

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

2 months / nytimes / Rebecca Robbins and Gina Kolata


Research advances: diagnostics and targeted therapies for pancreatic cancer

Michael Chuong: 4-Year Success Using Ablative Radiation for Advanced Pancreatic Cancer

2 months / oncodaily

Anirban Maitra: Strong Showing from NYU Langone Health at the Pancreas Club Meeting in Chicago

2 months / oncodaily

Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions

2 months / nature

Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer

2 months / medicalxpress

Microchip nanoparticle test spots pancreatic cancer in blood, outperforming biopsy in early trial

2 months / medicalxpress


All Other Stories

Phase 2 nITRO Trial: Perioperative NALIRIFOX in resectable PDAC

1 month / oncodaily

Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma

1 month / esmo

How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

1 month / nytimes / Gina Kolata and Rebecca Robbins

Dan Zhao: A New Article on Pancreatic Cancer

2 months / oncodaily

Daraxonrasib Shows Antitumor Activity in Previously Treated RAS-Mutated Pancreatic Cancer

2 months / oncodaily

Chadi Nabhan: Discussing Elraglusib Activity in Pancreatic Cancer With Deva Mahalingam

2 months / oncodaily

RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer

2 months / medicalxpress

Pancreatic cancer drug extends survival 8.5 months: Study

2 months / beckershospitalreview / Elizabeth Gregerson

New AI model spots pancreatic cancer up to 3 years earlier than human doctors in test

2 months / livescience

Machine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma

2 months / nature

Ahmet Dirican: Pancreatic Cancer May Be Entering a New Era

2 months / oncodaily

Yan Leyfman: Redefining What’s Biologically Possible in Pancreatic Cancer

2 months / oncodaily

Pashtoon Kasi: FDA Expands Access to DaraxonRASib for Pancreatic Cancer

2 months / oncodaily

Yannick Neuder: Grenoble Alpes University Hospital Achieves a European First in the Fight Against Pancreatic Cancer

2 months / oncodaily

Back to Top / Sat, May 2, 2026, 4:21 pm / permalink 23136 / 25 stories in 2 months /



Back to Top


PANCREATICCANCER Heatmap

90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Research Funding, Clinical Trials, Animal Health, Digital Health and look for the RSS link.

Back to Top
↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.